Press release
The Elastomer Infusion Pump Market size was valued USD 1.03 billion in 2022 and is estimated to reach USD 2.28 billion by 2030, growing at a CAGR of 8.7% during the forecast period (2024-2031).
Market growth is driven by the rising demand for ambulatory and pain management therapies, increasing adoption of cost-effective disposable infusion devices, and strong clinical outcomes associated with elastomer-based pumps. Advancements in biocompatible materials, expanding applications in chemotherapy and pediatrics, growing investments in home healthcare, and increased regulatory approvals for portable infusion systems are further accelerating market expansion.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/elastomer-infusion-pump-market?ram
Key Industry Developments
United States:
✅ January 2026: B. Braun received FDA 510(k) clearance for its next-generation Spaceplus elastomeric infusion pump, enhancing precision drug delivery for ambulatory pain management and chemotherapy with improved flow rate accuracy and patient safety features.
✅ December 2025: Spirit Medical fully launched the MedFuser elastomeric pump following NAPS preview, offering versatile configurations and industry-leading flow rates for post-operative infusions.
✅ October 2025: Baxter International upgraded its elastomeric pump line with variable-rate technology, FDA-approved for enhanced chemotherapy delivery in oncology centers.
This innovation addresses customized dosing needs for cancer patients.
Asia Pacific / Japan:
✅ November 2025: Terumo Corporation introduced a new elastomeric infusion pump in Japan, certified under PMDA guidelines for precise antibiotic administration in home care.
✅ October 2025: Nipro Corporation launched an AgTech-inspired smart elastomer pump in Asia Pacific markets, incorporating IoT monitoring for agricultural biotech infusion therapies with Japanese regulatory approval.
✅ September 2025: The Japanese MHLW granted fast-track approval to B. Braun's localized elastomeric pump variant, enabling wider use in hospital-to-home transitions for pain management.
Key Players:
B. Braun Melsungen AG | Baxter International Inc. | Halyard Health | Heka Healthcare | Nipro Medical Corporation | Palex Medical SA | Hospira Inc. (Pfizer Inc.)
Strategic Leadership Report: Top 5 Players in Elastomer Infusion Pump Market 2026
-B. Braun Melsungen AG: Launched the Easypump ST/LT elastomeric pump systems featuring a patented Sliding Core technology for precise, consistent short- and long-term infusions, enabling reliable medication delivery via positive pressure from the elastomeric membrane against vascular back-pressure.
-Baxter International Inc.: Advanced elastomeric infusion solutions with continuous flow regulation for controlled ambulatory drug administration, supporting patient mobility in chemotherapy and pain management through compact, non-electronic designs optimized for outpatient settings.
-Halyard Health (Avanos Medical): Developed specialized elastomeric pumps for post-surgical pain relief and antibiotic therapy, incorporating flow restrictors and variable-rate mechanisms to ensure accurate dosing over extended periods without power dependency.
-Nipro Medical Corporation: Expanded its elastomeric portfolio with innovative disposable pumps tailored for home-based infusion therapy, emphasizing user-friendly priming and broad compatibility with standard IV sets for enhanced accessibility in chronic care.
-Pfizer Inc. (Hospira Inc.): Pioneered reliable elastomeric infusion devices for steady-state drug delivery in oncology and palliative care, featuring pre-filled options and precise flow control to minimize clinician intervention and improve patient safety in decentralized healthcare.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=elastomer-infusion-pump-market?ram
Market Drivers and Key Trends:
-Chronic Disease Rise: Increasing prevalence of cancer, pain conditions, and infections drives demand for continuous-rate elastomer infusion pumps in chemotherapy, post-operative pain management, and home healthcare.
-Home Care Shift: Preference for cost-effective, portable devices supports long-term outpatient treatments, reducing hospital burdens amid rising healthcare costs.
-Technological Advances: Innovations in elastomer materials enhance flow precision and compatibility with viscous drugs, boosting adoption in oncology and antibiotic therapy.
-Regulatory Support: FDA guidelines and infection control standards promote reliable, low-complication pumps, while Asia-Pacific R&D growth offers expansion opportunities.
Regional Insights:
-North America: 41.7% (Largest share, driven by advanced healthcare infrastructure, high adoption of home-based therapies, and strong focus on patient safety in the U.S. and Canada).
-Asia Pacific: 20% (Fastest growing, fueled by rising orthopedic surgeries, healthcare expansion in India and China, and increasing chronic disease management).
-Europe: 18% (Supported by regulatory approvals, steady investments in medical devices, and demand in pain management across Germany, France, and the UK).
-Latin America: 10% (Emerging growth from rising cancer cases in Brazil and need for portable chemotherapy delivery).
-Middle East and Africa: 10% (Gaining traction via healthcare infrastructure buildup, such as new hospitals in UAE, for post-surgical care).
Market Opportunities & Challenges: Elastomer Infusion Pump Market 2026
-Opportunities: A "Home-Care Surge" accelerates adoption, with portable -elastomeric pumps projecting a 7.3% CAGR through 2033, driven by North America's 41.7% dominance. Pain management applications (39.8% share) and Asia-Pacific orthopedic booms, alongside ESG-aligned disposable designs for chemo/antibiotics, enable low-risk entry for precision-delivery innovators.
-Challenges: "Regulatory Fragmentation" burdens vary by region, inflating compliance costs amid chronic disease prevalence, while high initial investments compete with electronic alternatives. Aging demographics strain supply chains, demanding navigation of entrenched players like Baxter and B. Braun.
-Strategic Verdict: Continuous-rate pumps for post-surgical pain and outpatient therapy propel 2026 growth, prioritizing portable, single-use innovations in emerging markets.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/elastomer-infusion-pump-market?ram
Market Segmentation Analysis:
-By Product Type: Continuous Rate Pumps Lead for Steady Delivery
Continuous rate pumps hold the largest share at 60% in 2024, preferred for precise, uninterrupted medication infusion in critical care and post-surgery.
Variable rate pumps capture 40%, valued for adjustable dosing flexibility in dynamic treatments like pain control.
-By Application: Pain Management Dominates Amid Chronic Needs
Pain management commands 45% market share, driven by opioid alternatives and post-operative demands for controlled analgesia.
Chemotherapy follows at 25%, essential for precise chemo drug delivery to minimize side effects.
Infection management takes 20%, supporting antibiotic infusions in sepsis cases.
Others account for 10%, covering hydration and nutrition therapies.
-By End-Users: Hospitals and Clinics Hold Top Share
Hospitals and clinics lead with 55% share, central to inpatient infusions and specialized monitoring.
Home care follows at 25%, growing via patient mobility and cost savings.
Ambulatory care claims 15%, aiding outpatient procedures.
Others hold 5%, including specialty centers.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?ram
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTW
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: [email protected]
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Delete press release Edit press release News-ID: 4378727 • Views: 5
